Health

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda

ROCKVILLE, Md. and SUZHOU, China, June 21, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the agreed equity investment by Takeda has bee...

2024-06-21 09:19 4228

USANA Philippines Joins DSAP as its Newest Official Member

MANILA, Philippines, June 21, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, is proud to announce that itsPhilippines market has been unanimously approved to become the newest member of the Direct Selling Association ofthe Philippines (DSAP). This is a significant...

2024-06-21 07:07 3350

Tobii launches Tobii Nexus - webcam eye tracking for integration into any device or application

TAIPEI, June 20, 2024 /PRNewswire/ -- A software-only integration platform that enables eye tracking capabilities for devices with a webcam, helping developers create smarter abilities and interactivity within their applications – for any user, on any device. Tobii, the global leader in eye tr...

2024-06-20 18:00 2503

Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM

CHENGDU, China, June 20, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced that Lei Zhang/Renchi Yang's team from the Institute of Hematology, Chinese Academy of Medical Sciences has recently published a research paper entitled "A Novel Anti-CD38 Monoclonal Antibody for T...

2024-06-20 14:51 1504

Ping An Receives Five "All-Asia Executive Team 2024" Accolades From Institutional Investor Magazine

HONG KONG and SHANGHAI, June 20, 2024 /PRNewswire/ -- Institutional Investor magazine has announced the ranking of 2024 Asia (ex-Japan) Executive Team. Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) is delighted...

2024-06-20 12:26 4427

GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group

* GC Cell and PT Bifarma Adiluhung announced a strategic partnership to facilitate the entry of 'Immuncell-LC', the only approved autologous T-cell therapy for HCC into the Indonesian market. YONGIN, South Korea, June 19, 2024 /PRNewswire/ --GC Cell , a fully inte...

2024-06-20 08:44 2013

SINBON and MAKALOT partner to drive cross-industry textile wearable adoption

SAN FRANCISCO, June 19, 2024 /PRNewswire/ -- Digital technology is playing a transformative role in our everyday life, shaping not only how we interact with the world around us but also ourselves. The impact of this trend is most prevalent when examining the wellness landscape, where consumers co...

2024-06-20 00:00 2242

CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A

ATLANTA, June 19, 2024 /PRNewswire/ -- The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has formed a strategic partnership with ReviR Therapeutics to advance small molecule therapeutics that modulate the expressio...

2024-06-19 21:00 1760

Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

* Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational pivotal JACKPOT8B study. * Golidocitinib monotherapy demonstrated superior and durable clinical benefits and a favorable safety profile in r/...

2024-06-19 19:30 1967

GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation

SHANGHAI, June 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announcedChina's National Medical Products Administration (NMPA) has approved the clinical trial application for GFH375 (VS-7375) in...

2024-06-19 19:00 1898

Ping An Announces Brand Upgrade of "Ping An Family Doctor"

HONG KONG and SHANGHAI, June 19, 2024 /PRNewswire/ -- The "Ping An Family Doctor Brand Upgrade Conference" was held inShanghai recently. Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has upgraded its "Ping An Family Doctor" ...

2024-06-19 18:15 4116

Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health

BEIJING, June 19, 2024 /PRNewswire/ -- Recently, Professor Jianping Weng of the University of Science and Technology ofChina (USTC) and President of Anhui Medical University and his team of researchers from USTC, Southern Medical University and Peking University published the results of their lat...

2024-06-19 18:10 1568

Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens

ATHENS, Greece, June 19, 2024 /PRNewswire/ -- Smartee Denti-Technology, a pioneer in clear aligner industry with 20 years of independent research & development and over 850 patents applied, shared its two decades of achievement and full series of products at the 99th Congress of the European Orth...

2024-06-19 16:44 1448

Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report

Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has re...

2024-06-19 15:00 1565

VUNO PRESENTS CUTTING-EDGE AI BRAIN TECHNOLOGY AT AAIC - ANALYZING MRI SCANS IN <1 MINUTE TO SUPPORT DIAGNOSIS OF ALZHEIMER'S DISEASE

Potential partners are invited to explore collaboration opportunities with VUNO Med®-DeepBrain®, a highly accurate AI solution for research and clinical settings. MARLBOROUGH, Mass., June 17, 2024 /PRNewswire/ -- VUNO — acclaimed as a pioneer in AI-based medical solutions—announ...

2024-06-19 14:14 2874

Tang Prize in Biopharmaceutical Science Honoring Three Scientists

TAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundationtoday (June 19th) announced the 2024 Tang Prize in Biopharmaceutical Science recipients. The prestigious award has been jointly awarded toJoel F. Habener, Svetlana Mojsov, and Jens Juu...

2024-06-19 12:15 1518

Innovent Reports Oncology Pipeline Updates at Investor Meeting

SAN FRANCISCO and SUZHOU, China, June 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and o...

2024-06-19 10:55 4304

Menarini Asia-Pacific partners with Pharmacosmos to expand its reach of MonoFer® to Singapore and Malaysia

SINGAPORE, June 19, 2024 /PRNewswire/ -- Menarini Asia-Pacific (Menarini) today announced that it has expanded its partnership with Pharmacosmos A/S (Pharmacosmos), to include exclusive rights to commercialiseMonoFer® (ferric derisomaltose) in Singapore and Malaysia. This builds upon the successf...

2024-06-19 09:43 2188

ZA Tech Rebrands as Peak3, Raises US$35M Series A led by EQT

SINGAPORE, June 19, 2024 /PRNewswire/ -- ZA Tech, the next-generation insurance core system SaaS provider, has rebranded asPeak3 . With the successful completion of itsUS$35 million Series A fundraising from EQT (lead investor) and Alpha JWC Ventures,Peak3 now accelerates i...

2024-06-19 09:00 2723

YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China

Strategic Partnership to Advance Gene Editing Technologies in Biomedical Applications SHANGHAI, June 18, 2024 /PRNewswire/ -- YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery forin vivo gene editing therapies, has partnered with KACTUS, a leading developer se...

2024-06-19 09:00 1607
1 ... 66676869707172 ... 858